Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 51.6 | 30.5 | 11.0 | 2.4 |
| General and administrative | 24.9 | 18.1 | 9.7 | 8.7 |
| EBIT | -76.5 | -48.6 | -20.7 | -11.1 |
| Pre-tax income | -73.5 | -50.8 | -21.2 | -11.3 |
| Income taxes | 0.0 | -0.3 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.6% | 0.0% | 0.0% |
| Net income | -73.5 | -50.5 | -21.2 | -11.3 |
| |
| Diluted EPS | ($3.59) | ($5.19) | ($12.49) | ($6.61) |
| Shares outstanding (diluted) | 20.5 | 9.7 | 1.7 | 1.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|